Chung-Han Lee

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Topics

Renal Cell Carcinoma

Smoking Cessation

Combination Therapy

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature reviews. Urology

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Brendan J Guercio, Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Duzgol, Samuel A Funt, Chung-Han Lee, David Henry Aggen, Ashley M Regazzi, Zhiyu Chen, Michael Lattanzi, Hikmat A Al-Ahmadie, Angela Rose Brannon, Ronak H Shah, Carissa E Chu, Andrew T Lenis, Eugene J Pietzak, Bernard H Bochner, Michael F Berger, David B Solit, Jonathan E Rosenberg, Dean F Bajorin, Gopakumar V Iyer
Clinical and genomic landscape of FGFR3-altered urothelial carcinoma and treatment outcomes with erdafitinib: a real-world experience. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ritesh R Kotecha, Andrea Knezevic, Kanika S Arora, Chaitanya Bandlamudi, Fengshen Kuo, Maria Isabel Carlo, Kelly N Fitzgerald, Darren R Feldman, Neil J Shah, Ed Reznik, Abraham Ari Hakimi, Jian Carrot-Zhang, Diana L Mandelker, Michael F Berger, Chung-Han Lee, Robert J Motzer, Martin H Voss
Genomic ancestry in kidney cancer: Correlations with clinical and molecular features. Cancer (2023)
Yasser Ged, Alejandro Sanchez, Sujata Patil, Andrea Knezevic, Emily Stein, Stacey Petruzella, Kate Weiss, Cihan Duzgol, Joshua Chaim, Oguz Akin, Marina Mourtzakis, Michael T Paris, Jessica M Scott, Fengshen Kuo, Ritesh R Kotecha, Abraham Ari Hakimi, Chung-Han Lee, Robert J Motzer, Martin H Voss, Helena Furberg
Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Ritesh R Kotecha, Erika Gedvilaite, Ryan Ptashkin, Andrea Knezevic, Samuel Murray, Ian Johnson, Natalie Shapnik, Darren R Feldman, Maria Isabel Carlo, Neil J Shah, Marisa Dunigan, Kety Huberman, Ryma Benayed, Ahmet Zehir, Michael F Berger, Marc Ladanyi, Dana Wai Yi Tsui, Robert J Motzer, Chung-Han Lee, Martin H Voss
Matched Molecular Profiling of Cell-Free DNA and Tumor Tissue in Patients With Advanced Clear Cell Renal Cell Carcinoma. JCO precision oncology 6 (2022)
Chung-Han Lee, Martin H Voss, Maria Isabel Carlo, Ying-Bei Chen, Mark Zucker, Andrea Knezevic, Robert A Lefkowitz, Natalie Shapnik, Chloe Dadoun, Ed Reznik, Neil J Shah, Colette Ngozi Owens, Deaglan Joseph McHugh, David Henry Aggen, Andrew Leonard Laccetti, Ritesh R Kotecha, Darren R Feldman, Robert J Motzer
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (21) (2022)
Ramin Sedaghat Herati, David A Knorr, Laura A Vella, Luisa Victoria Silva, Lakshmi Chilukuri, Sokratis A Apostolidis, Alexander C Huang, Alexander Muselman, Sasikanth Manne, Oliva Kuthuru, Ryan P Staupe, Sharon A Adamski, Senthil Kannan, Raj K Kurupati, Hildegund C J Ertl, Jeffrey L Wong, Stylianos Bournazos, Suzanne McGettigan, Lynn M Schuchter, Ritesh R Kotecha, Samuel A Funt, Martin H Voss, Robert J Motzer, Chung-Han Lee, Dean F Bajorin, Tara C Mitchell, Jeffrey V Ravetch, E John Wherry
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine. Nature immunology 23 (8) (2022)
Samuel A Funt, Michael Lattanzi, Karissa A Whiting, Hikmat A Al-Ahmadie, Colleen Quinlan, Min Yuen Teo, Chung-Han Lee, David Henry Aggen, Danielle Zimmerman, Deaglan Joseph McHugh, Arlyn Apollo, Trey D Durdin, Hong Truong, Jeffrey Kamradt, Maged Khalil, Bradley Lash, Irina Ostrovnaya, Asia S McCoy, Grace Hettich, Ashley M Regazzi, Marwah Jihad, Neha Ratna, Abigail Boswell, Kaitlyn Francese, Yuanquan Yang, Edmund Folefac, Harry W Herr, S Machele Donat, Eugene J Pietzak, Eugene K Cha, Timothy F Donahue, Alvin C Goh, William C Huang, Dean F Bajorin, Gopakumar V Iyer, Bernard H Bochner, Arjun V Balar, Amir Mortazavi, Jonathan E Rosenberg
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (12) (2022)
Kelly N Fitzgerald, Robert J Motzer, Chung-Han Lee
Adjuvant therapy options in renal cell carcinoma - targeting the metastatic cascade. Nature reviews. Urology (2022)
Chung-Han Lee, Robert J Motzer, Hamid Emamekhoo, Marc Matrana, Ivor J Percent, James J Hsieh, Arif Hussain, Ulka Vaishampayan, Sandy Liu, Steven McCune, Vijay Patel, Montaser Shaheen, Johanna Bendell, Alice C Fan, Benjamin A Gartrell, Oscar B Goodman, Petros G Nikolinakos, Arash Rezazadeh Kalebasty, Yousef Zakharia, Zhentao Zhang, Hema Parmar, Lalith Akella, Keith Orford, Nizar M Tannir
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Kyrollis Attalla, Renzo G DiNatale, Phillip M Rappold, Christopher J Fong, Francisco Sanchez-Vega, Andrew W Silagy, Stanley Weng, Jonathan Coleman, Chung-Han Lee, Maria Isabel Carlo, Jeremy C Durack, Stephen B Solomon, Victor E Reuter, Paul Russo, Timothy A Chan, Robert J Motzer, Nikolaus D Schultz, Ed Reznik, Martin H Voss, A Ari Hakimi
Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)
Meredith M Regan, Opeyemi A Jagede, Charlene M Mantia, Thomas Powles, Lillian Werner, Robert J Motzer, Nizar M Tannir, Chung-Han Lee, Yoshihiko Tomita, Martin H Voss, Elizabeth R Plimack, Toni K Choueiri, Brian I Rini, Hans J Hammers, Bernard Escudier, Laurence Albiges, Stephen Huo, Viviana Del Tejo, Brian Stwalley, Michael B Atkins, David F McDermott
Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Michal Sarfaty, Karissa A Whiting, Min Yuen Teo, Chung-Han Lee, Vanessa Peters, Jennifer Durocher, Ashley M Regazzi, Asia S McCoy, Grace Hettich, Achim A Jungbluth, Hikmat A Al-Ahmadie, Irina Ostrovnaya, Joshua Chaim, Dean F Bajorin, Jonathan E Rosenberg, Gopakumar V Iyer, Samuel A Funt
A phase II trial of durvalumab and tremelimumab in metastatic, non-urothelial carcinoma of the urinary tract. Cancer medicine 10 (3) (2020)
Yasser Ged, Ruby Gupta, Cihan Duzgol, Andrea Knezevic, Natalie Shapnik, Ritesh Kotecha, Martin H Voss, Darren R Feldman, Oguz Akin, Sujata Patil, Robert J Motzer, Brian I Rini, Chung-Han Lee
Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations. BMC urology 20 (1) (2020)
Chung-Han Lee, Robert J Motzer
Combination therapy for advanced and metastatic kidney cancer. Nature reviews. Urology 16 (2) (2019)